| Drug NDC: | 43742-1507 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. | |
| Proprietary Name: | Female Stimulant |
| Also known as the trade name. It is the name of the product chosen by the labeler. | |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. | |
| Non Proprietary Name: | Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Petroselinum Sativum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (suis), Kreosotum, Oophorinum (suis), Uterus (suis), Folliculinum, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (suis), Hypophysis Suis, Aconiticum Acidum Cis-, Apis Venenum Purum, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Faecalis (alkaligenes), Mutabile Bacillus (bach) |
| Also known as the generic name, this is usually the active ingredient(s) of the product. | |
| Labeler Name: | Deseret Biologicals, Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. | |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. | |
| Substance Name: | ACONITIC ACID, (Z)- - 10 [hp_X]/mL ALCALIGENES FAECALIS - 30 [hp_C]/mL APIS MELLIFERA VENOM - 18 [hp_X]/mL AQUILEGIA VULGARIS - 8 [hp_X]/mL CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT - 6 [hp_X]/mL ESCHERICHIA COLI - 30 [hp_C]/mL ESTRADIOL - 30 [hp_X]/mL ESTRONE - 8 [hp_X]/mL GOLDENSEAL - 6 [hp_X]/mL LACHESIS MUTA VENOM - 10 [hp_X]/mL Load more... LILIUM LANCIFOLIUM WHOLE FLOWERING - 4 [hp_X]/mL LYCOPERDON UTRIFORME FRUITING BODY - 6 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - 10 [hp_X]/mL MERCURIUS SOLUBILIS - 12 [hp_X]/mL PETROSELINUM CRISPUM - 6 [hp_X]/mL PORK HEART - 8 [hp_X]/mL PROGESTERONE - 30 [hp_X]/mL SEPIA OFFICINALIS JUICE - 13 [hp_X]/mL SUS SCROFA ADRENAL GLAND - 8 [hp_X]/mL SUS SCROFA OVARY - 8 [hp_X]/mL SUS SCROFA PINEAL GLAND - 16 [hp_X]/mL SUS SCROFA PITUITARY GLAND - 10 [hp_X]/mL SUS SCROFA PLACENTA - 6 [hp_C]/mL SUS SCROFA UMBILICAL CORD - 8 [hp_X]/mL SUS SCROFA UTERUS - 8 [hp_X]/mL TESTOSTERONE - 30 [hp_X]/mL WOOD CREOSOTE - 8 [hp_X]/mL |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. | |
| Route Details: | ORAL |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Start Date: | 20 Aug, 2019 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. | |
| Marketing End Date: | 09 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. | |
| Listing Expiration Date: | 31 Dec, 2024 |
| This is the date when the listing record will expire if not updated or certified by the firm. | |
| Manufacturer Name: | Deseret Biologicals, Inc. |
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. | |
| Original Packager: | Yes |
| Whether or not the drug has been repackaged for distribution. | |
| NUI: | M0447348 N0000175825 N0000000100 M0017672 N0000175601 N0000175824 N0000000146 M0001109 |
| Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT). | |
| UNII: | OF5471ZHRR 05KB30NGW2 76013O881M 8POZ61U1G2 21Y9GZ1LZA 514B9K0L10 4TI98Z838E 2DI9HA706A ZW3Z11D0JV VSW71SS07I Load more... X67Z2963PI K2A74U428F HF539G9L3Q 324Y4038G2 1WZA4Y92EX X876KJM95L 4G7DS2Q64Y QDL83WN8C2 398IYQ16YV S7YTV04R8O 050QZ2EDK7 L0PFEMQ1DT C8CV8867O8 118OYG6W3H 2595C75F1P 3XMK78S47O 3JYG22FD73 |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. | |
| Pharmacologic Class MOA: | Estrogen Receptor Agonists [MoA] Androgen Receptor Agonists [MoA] |
| Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`. | |
| Pharmacologic Class EPC: | Estrogen [EPC] Progesterone [EPC] Androgen [EPC] |
| Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`. | |
| Pharmacologic Class CS: | Estradiol Congeners [CS] Progesterone [CS] Androstanes [CS] |
| Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient]. | |
| Pharmacologic Class: | Androgen Receptor Agonists [MoA] Androgen [EPC] Androstanes [CS] Calculi Dissolution Agent [EPC] Estradiol Congeners [CS] Estrogen Receptor Agonists [MoA] Estrogen [EPC] Increased Large Intestinal Motility [PE] Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] Inhibition Small Intestine Fluid/Electrolyte Absorption [PE] Magnesium Ion Exchange Activity [MoA] Osmotic Activity [MoA] Osmotic Laxative [EPC] Progesterone [CS] Progesterone [EPC] Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. | |
| DEA Schedule: | CIII |
| This is the assigned DEA Schedule number as reported by the labeler. Values are CI, CII, CIII, CIV, and CV. | |
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|---|---|---|---|
| 43742-1507-1 | 30 mL in 1 BOTTLE, DROPPER (43742-1507-1) | 20 Aug, 2019 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. | ||||
* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.